Skip to main content

Advertisement

Log in

Cerebral Venous Thrombosis: an Update

  • Stroke (H.C. Diener, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The purpose of this update is to summarize the recent advances on the management of cerebral venous thrombosis (CVT).

Recent Findings

There is a trend in declining frequency of CVT patients presenting with focal deficits or coma and a decrease in mortality over time. Anemia and obesity were identified as risk factors for CVT. During pregnancy and puerperium, the higher risk of CVT occurs in the first months post-delivery. With appropriate management, 1/3 of comatose CVT patients can have a full recovery.

Summary

The management of CVT patients includes treatment of associated conditions, anticoagulation with parenteral heparin, prevention of recurrent seizures, and decompressive neurosurgery in patients with large venous infarcts/hemorrhages with impending herniation. After the acute phase, patients should be anticoagulated for 3–12 months. Results of recently completed randomized controlled trials on endovascular treatment and comparing dabigatran with warfarin will improve the treatment of CVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ageno W, Beyer-Westendorf J, Garcia D, Lazo-Langner A, McBane R, Paciaroni M. Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis. 2016;41(2016):129–43.

    Article  CAS  Google Scholar 

  2. Ferro JM, Canhão P, Aguiar de Sousa D. Cerebral venous thrombosis. Presse Med. 2016;45(12 Pt 2):e429–50. https://doi.org/10.1016/j.lpm.2016.10.007.

    Article  PubMed  Google Scholar 

  3. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65. https://doi.org/10.1038/nrneurol.2017.104.

    Article  PubMed  Google Scholar 

  4. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012;43(12):3375–7. https://doi.org/10.1161/STROKEAHA.112.671453.

    Article  Google Scholar 

  5. Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47(9):2180–2. https://doi.org/10.1161/STROKEAHA.116.013617.

    Article  Google Scholar 

  6. Coutinho JM, Zuurbier SM, Stam J. Declining mortality in cerebral venous thrombosis: a systematic review. Stroke. 2014;45(2014):1338–41.

    Article  Google Scholar 

  7. Zuurbier SM, Middeldorp S, Stam J, Coutinho JM. Sex differences in cerebral venous thrombosis: a systematic analysis of a shift over time. Int J Stroke. 2016;11(2):164–70. https://doi.org/10.1177/1747493015620708.

    Article  PubMed  Google Scholar 

  8. Zuurbier SM, Hiltunen S, Lindgren E, Silvis SM, Jood K, Devasagayam S, et al. Cerebral venous thrombosis in older patients. Stroke. 2018;49(1):197–200. https://doi.org/10.1161/STROKEAHA.117.019483.

    Article  PubMed  Google Scholar 

  9. •• Green M, Styles T, Russell T, Sada C, Jallow E, Stewart J, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15–22. https://doi.org/10.1016/j.thromres.2018.07.005 A systematic review and odds ratio for some non-genetic and genetic risk factors for adult CVT.

    Article  CAS  PubMed  Google Scholar 

  10. • Silvis SM, Lindgren E, Hiltunen S, Devasagayam S, Scheres LJ, Jood K, et al. Postpartum period is a risk factor for cerebral venous thrombosis. Stroke. 2019;50(2):501–3. https://doi.org/10.1161/STROKEAHA.118.023017 A case-control study concluding that the risk of CVT is higher during the first 6 weeks postpartum.

    Article  PubMed  Google Scholar 

  11. Zuurbier SM, Arnold M, Middeldorp S, Broeg-Morvay A, Silvis SM, Heldner MR, et al. Risk of cerebral venous thrombosis in obese women. JAMA Neurol. 2016;73(2016):579–84.

    Article  Google Scholar 

  12. • Silvis SM, Hiltunen S, Lindgren E, Jood K, Zuurbier SM, Middeldorp S, et al. Cancer and risk of cerebral venous thrombosis: a case-control study. J Thromb Haemost. 2018;16(1):90–5. https://doi.org/10.1111/jth.13903 A case-control study confirming that cancer is a risk factor for CVT.

    Article  CAS  PubMed  Google Scholar 

  13. Ranta S, Tuckuviene R, Mäkipernaa A, Albertsen BK, Frisk T, Tedgård U, et al. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology. Br J Haematol. 2015 Feb;168(4):547–52. https://doi.org/10.1111/bjh.13162.

    Article  PubMed  Google Scholar 

  14. Ghanem KM, Dhayni RM, Al-Aridi C, Tarek N, Tamim H, Chan AKC, et al. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: risk factors and management. Pediatr Blood Cancer. 2017;64(12). https://doi.org/10.1002/pbc.26694.

    Article  Google Scholar 

  15. Zuurbier SM, Lauw MN, Coutinho JM, Majoie CB, van der Holt B, Cornelissen JJ, et al. Clinical course of cerebral venous thrombosis in adult acute lymphoblastic leukemia. J Stroke Cerebrovasc Dis. 2015;24(7):1679–84. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.041.

    Article  PubMed  Google Scholar 

  16. Lee KR, Subrayan V, Win MM, Fadhilah Mohamad N, Patel D. ATRA-induced cerebral sinus thrombosis. J Thromb Thrombolysis. 2014 Jul;38(1):87–9. https://doi.org/10.1007/s11239-013-0988-7.

    Article  PubMed  Google Scholar 

  17. Coutinho JM, Zuurbier SM, Gaartman AE, Dikstaal AA, Stam J, Middeldorp S, et al. Association between anemia and cerebral venous thrombosis: case-control study. Stroke. 2015;46(10):2735–40. https://doi.org/10.1161/STROKEAHA.115.009843.

    Article  CAS  PubMed  Google Scholar 

  18. Vecht L, Zuurbier SM, Meijers JCM, Coutinho JM. Elevated factor VIII increases the risk of cerebral venous thrombosis: a case-control study. J Neurol. 2018;265(7):1612–7. https://doi.org/10.1007/s00415-018-8887-7.

    Article  CAS  PubMed  Google Scholar 

  19. Uluduz D, Midi I, Duman T, Colakoglu S, Tüfekci A, Bakar M, et al. Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study. Rheumatology (Oxford). 2019;58(4):600–8. https://doi.org/10.1093/rheumatology/key153.

    Article  Google Scholar 

  20. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664–70.

    Article  Google Scholar 

  21. • Duman T, Uluduz D, Midi I, Bektas H, Kablan Y, Goksel BK, et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis. 2017;26(8):1848–57. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.04.020 The largest published CVT series. The study is however retrospective.

    Article  PubMed  Google Scholar 

  22. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36(9):1927–32.

    Article  Google Scholar 

  23. Coutinho JM, Gerritsma JJ, Zuurbier SM, Stam J. Isolated cortical vein thrombosis: systematic review of case reports and case series. Stroke. 2014;45(6):1836–8. https://doi.org/10.1161/STROKEAHA.113.004414.

    Article  PubMed  Google Scholar 

  24. Panda S, Prashantha DK, Shankar SR, Nagaraja D. Localized convexity subarachnoid haemorrhage--a sign of early cerebral venous sinus thrombosis. Eur J Neurol. 2010;17:1249–58.

    Article  CAS  Google Scholar 

  25. Geraldes R, Sousa PR, Fonseca AC, Falcao F, Canhao P, Pinho e Melo T. Nontraumatic convexity subarachnoid hemorrhage: different etiologies and outcomes. J Stroke Cerebrovasc Dis. 2014;23(1):e23–30. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.08.005.

    Article  PubMed  Google Scholar 

  26. Fu FW, Rao J, Zheng YY, Song L, Chen W, Zhou QH, et al. Perimesencephalic nonaneurysmal subarachnoid hemorrhage caused by transverse sinus thrombosis: a case report and review of literature. Medicine (Baltimore). 2017;96(33):e7374. https://doi.org/10.1097/MD.0000000000007374.

    Article  Google Scholar 

  27. Azeemuddin M, Awais M, Mubarak F, Rehman A, Baloch NU. Prevalence of subarachnoid haemorrhage among patients with cranial venous sinus thrombosis in the presence and absence of venous infarcts. Neuroradiol J. 2018;31(5):496–503. https://doi.org/10.1177/1971400918783060.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Leavell Y, Khalid M, Tuhrim S, Dhamoon MS. Baseline characteristics and readmissions after cerebral venous sinus thrombosis in a nationally representative database. Cerebrovasc Dis. 2018;46(5–6):249–56. https://doi.org/10.1159/000495420.

    Article  PubMed  Google Scholar 

  29. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39(4):1152–8. https://doi.org/10.1161/STROKEAHA.107.487363.

    Article  PubMed  Google Scholar 

  30. Masuhr F, Busch M, Amberger N, Ortwein H, Weih M, Neumann K, et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13(2006):852–6.

    Article  CAS  Google Scholar 

  31. Mahale R, Mehta A, John AA, Buddaraju K, Shankar AK, Javali M, et al. Acute seizures in cerebral venous sinus thrombosis: what predicts it? Epilepsy Res. 2016;123(2016):1–5.

    Article  Google Scholar 

  32. Ding H, Xie Y, Li L, Chu H, Tang Y, Dong Q, et al. Clinical features of seizures after cerebral venous sinus thrombosis and its effect on outcome among Chinese Han population. Stroke Vasc Neurol. 2017;2(4):184–8. https://doi.org/10.1136/svn-2017-000095 eCollection.

    Article  PubMed  PubMed Central  Google Scholar 

  33. • Kalita J, Misra UK, Singh VK, Dubey D. Predictors and outcome of status epilepticus in cerebral venous thrombosis. J Neurol. 2019;266(2):417–25. https://doi.org/10.1007/s00415-018-9145-8 A large case series comparing CVT patients without and with seizures, including 18% with status epilepticus.

    Article  PubMed  Google Scholar 

  34. Kowoll CM, Kaminski J, Weiss V, Bosel J, Dietrich W, Juttler E, et al. Severe cerebral venous and sinus thrombosis: clinical course, imaging correlates, and prognosis. Neurocrit Care. 2016;25(3):392–9.

    Article  Google Scholar 

  35. Soyer B, Rusca M, Lukaszewicz AC, Crassard I, Guichard JP, Bresson D, et al. Outcome of a cohort of severe cerebral venous thrombosis in intensive care. Ann Intensive Care. 2016;6(1):29. https://doi.org/10.1186/s13613-016-0135-7 Erratum in: Ann Intensive Care.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ferro JM, Bacelar-Nicolau H, Rodrigues T, Bacelar-Nicolau L, Canhão P, Crassard I, et al. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2009;28(1):39–44. https://doi.org/10.1159/000215942.

    Article  PubMed  Google Scholar 

  37. Barboza MA, Chiquete E, Arauz A, Merlos-Benitez M, Quiroz-Compeán A, Barinagarrementería F, et al. A practical score for prediction of outcome after cerebral venous thrombosis. Front Neurol. 2018;9:882. https://doi.org/10.3389/fneur.2018.00882 eCollection 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  38. • Liberman AL, Gialdini G, Bakradze E, Chatterjee A, Kamel H, Merkler AE. Misdiagnosis of cerebral vein thrombosis in the emergency department. Stroke. 2018;49(6):1504–6. https://doi.org/10.1161/STROKEAHA.118.021058 A study using administrative data showing that misdiagnosis of CVT occurred in 1 out of 30 patients.

    Article  PubMed  PubMed Central  Google Scholar 

  39. •• Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195–221. https://doi.org/10.1177/2396987317719364 A comprehensive, evidence-based guideline addressing both diagnostic and therapeutic recommendations.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Dentali F, Squizzato A, Marchesi C, Bonzini M, Ferro JM, Ageno W. D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2012;10(4):582–9.

    Article  CAS  Google Scholar 

  41. Buyck PJ, de Keyzer F, Vanneste D, Wilms G, Thijs V, Demaerel D. CT density measurement and H:H ratio are useful in diagnosing acute cerebral venous sinus thrombosis. AJNR Am J Neuroradiol. 2013;34:1568–72.

    Article  Google Scholar 

  42. Rodallec MH, Krainik A, Feydy A, Hélias A, Colombani JM, Jullès MC, et al. Cerebral venous thrombosis and multidetector CT angiography: tips and tricks. Radiographics. 2006;26(Suppl 1):S5–18.

    Article  Google Scholar 

  43. Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke. 2006;37(4):991–5.

    Article  Google Scholar 

  44. Niu PP, Yu Y, Guo ZN, Jin H, Liu Y, Zhou HW, et al. Diagnosis of non-acute cerebral venous thrombosis with 3D T1-weighted black blood sequence at 3T. J Neurol Sci. 2016;367:46–50.

    Article  Google Scholar 

  45. Yang Q, Duan J, Fan Z, Qu X, Xie Y, Nguyen C, et al. Early detection and quantification of cerebral venous thrombosis by magnetic resonance black-blood thrombus imaging. Stroke. 2016;47(2):404–9.

    Article  Google Scholar 

  46. Rollins N, Ison C, Reyes T, Chia J. Cerebral MR venography in children: comparison of 2D time-of-flight and gadolinium-enhanced 3D gradient-echo techniques. Radiology. 2005;235(3):1011–7.

    Article  Google Scholar 

  47. Conforto AB, Nader SN, Puglia Junior P, Yamamoto FI, Gonçalves MR, Vasconcelos FR, et al. Dural arteriovenous fistula and cerebral venous thrombosis. Arq Neuropsiquiatr. 2015;73:548.

    Article  Google Scholar 

  48. Aguiar de Sousa D, Lucas Neto L, Jung S, Penas S, Panos L, Heldner MR, et al. Brush sign is associated with increased severity in cerebral venous thrombosis. Stroke. 2019;50(6):1574–7.

    Article  Google Scholar 

  49. Qureshi A, Perera A. Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: a systematic review and meta-analysis. Ann Med Surg (Lond). 2017;17:22–6.

    Article  Google Scholar 

  50. Hersh DS, Shimony N, Groves ML, Tuite GF, Jallo GI, Liu A, et al. Pediatric cerebral venous sinus thrombosis or compression in the setting of skull fractures from blunt head trauma. J Neurosurg Pediatr. 2018;21(3):258–69. https://doi.org/10.3171/2017.9.PEDS17311.

    Article  PubMed  Google Scholar 

  51. Zuurbier SM, Coutinho JM, Stam J, Canhão P, Barinagarrementeria F, Bousser MG, et al. Clinical outcome of anticoagulant treatment in head or neck infection-associated cerebral venous thrombosis. Stroke. 2016;47(5):1271–7. https://doi.org/10.1161/STROKEAHA.115.011875.

    Article  CAS  PubMed  Google Scholar 

  52. Aguiar de Sousa D, Ferro J, Canhao P, Barinagarrementeria F, Bousser M, Stam J, et al. Cerebral venous thrombosis causing posterior fossa lesions: description of a case series and assessment of safety of anticoagulation. Cerebrovasc Dis. 2014;38(2014):384–8.

    Article  Google Scholar 

  53. • Goedemans T, Verbaan D, Coert BA, Kerklaan BJ, van den Berg R, Coutinho JM, et al. Neurologic outcome after decompressive craniectomy: predictors of outcome in different pathologic conditions. World Neurosurg. 2017;105:765–74 A comparison of the outcome after decompressive craniectomy in several neurological diseases, showing that those with CVT had the better outcomes.

    Article  Google Scholar 

  54. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2011):1158–92.

    Article  Google Scholar 

  55. Lee SK, Mokin M, Hetts SW, Fifi JT, Bousser MG, Fraser JF, et al. Current endovascular strategies for cerebral venous thrombosis: report of the SNIS Standards and Guidelines Committee. J Neurointerv Surg. 2018;10(8):803–10.

    Article  Google Scholar 

  56. Siddiqui FM, Dandapat S, Banerjee C, Zuurbier SM, Johnson M, Stam J, et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke. 2015;46:1263–8.

    Article  Google Scholar 

  57. Coutinho JM, Ferro JM, Zuurbier SM, Mink MS, Canhão P, Crassard I, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke. 2013 Feb;8(2):135–40. https://doi.org/10.1111/j.1747-4949.2011.00753.x.

    Article  PubMed  Google Scholar 

  58. • Siddiqui FM, Weber MW, Dandapat S, Scaife S, Buhnerkempe M, Ortega-Gutierrez S, et al. Endovascular thrombolysis or thrombectomy for cerebral venous thrombosis: study of Nationwide Inpatient Sample 2004–2014. J Stroke Cerebrovasc Dis. 2019;28(6):1440–7 This study based on an administrative database showed that endovascular treatment was associated with worse outcomes.

    Article  Google Scholar 

  59. Ferro JM, Dentali F, Coutinho JM, Kobayashi A, Caria J, Desch M, et al. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis. Int J Stroke. 2018;13(7):766–70. https://doi.org/10.1177/1747493018778125.

    Article  PubMed  Google Scholar 

  60. Nasr DM, Brinjikji W, Cloft HJ, Saposnik G, Rabinstein AA. Mortality in cerebral venous thrombosis: results from the national inpatient sample database. Cerebrovasc Dis. 2013;35(1):40–4. https://doi.org/10.1159/000343653.

    Article  CAS  PubMed  Google Scholar 

  61. Liberman AL, Merkler AE, Gialdini G, Messé SR, Lerario MP, Murthy SB, et al. Risk of pulmonary embolism after cerebral venous thrombosis. Stroke. 2017;48(3):563–7.

    Article  Google Scholar 

  62. Lindgren E, Jood K, Tatlisumak T. Vocational outcome in cerebral venous thrombosis: long-term follow-up study. Acta Neurol Scand. 2018;137(3):299–307.

    Article  CAS  Google Scholar 

  63. Koban Y, Ozlece H, Karayol S, Huseyinoglu N. Decreased retinal nerve fiber layer thickness in patients with cerebral venous thrombosis. BMC Ophthalmol. 2019;19(1):57.

    Article  Google Scholar 

  64. Lim HY, Ng C, Donnan G, Nandurkar H, Ho P. Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events. Thromb Thrombolysis. 2016;42(3):423–31.

    Article  CAS  Google Scholar 

  65. Martinelli I, De Stefano V, Carobbio A, Randi ML, Santarossa C, Rambaldi A, et al. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study. Am J Hematol. 2014;89(11):E200–5.

    Article  Google Scholar 

  66. • Pires GS, Ribeiro DD, JAQ O, Freitas LC, Vaez R, Annichino-Bizzacchi JM, et al. Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: a cohort study. Thromb Res. 2019;178:85–90 A cohort study for Brazil reporting a lower risk of recurrent venous thromboembolism than previous investigations.

    Article  CAS  Google Scholar 

  67. •• Aguiar de Sousa D, Lucas Neto L, Canhão P, Ferro JM. Recanalization in cerebral venous thrombosis. Stroke. 2018;49(8):1828–35 A systematic review of recanalization after CVT, showing that recanalization occurs in up to 85% of the patients and is associated with better outcome.

    Article  Google Scholar 

  68. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, ; European Thromboses Study Group et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol 2007;6:595–603. doi: https://doi.org/10.1016/S1474-4422(07)70131-X.

    Article  PubMed  PubMed Central  Google Scholar 

  69. • Kashkoush AI, Ma H, Agarwal N, Panczykowski D, Tonetti D, Weiner GM, et al. Cerebral venous sinus thrombosis in pregnancy and puerperium: a pooled, systematic review. J Clin Neurosci. 2017;39:9–15 This systematic review confirms that CVT during pregnancy has usually a very good prognosis.

    Article  Google Scholar 

  70. •• Aguiar de Sousa D, Canhão P, Crassard I, Coutinho J, Arauz A, Conforto A, et al. Safety of pregnancy after cerebral venous thrombosis: results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study. Stroke. 2017;48(11):3130–3. https://doi.org/10.1161/STROKEAHA.117.018829 A 14-year follow-up study of women in fertile age from the ISCVT cohort, showing that recurrent venous thrombotic events were infrequent in subsequent pregnancies.

    Article  PubMed  Google Scholar 

  71. Martinelli I, Passamonti SM, Maino A, Abbattista M, Bucciarelli P, Somigliana E, et al. Pregnancy outcome after a first episode of cerebral vein thrombosis. J Thromb Haemost. 2016;14(12):2386–93.

    Article  CAS  Google Scholar 

  72. Aguiar de Sousa D, Canhão P, Ferro JM. Safety of pregnancy after cerebral venous hrombosis: a systematic review. Stroke. 2016;47(3):713–8.

    Article  CAS  Google Scholar 

  73. • Aguiar de Sousa D, Canhão P, Ferro JM. Safety of pregnancy after cerebral venous thrombosis: systematic review update. J Neurol. 2018;265(1):211–2. https://doi.org/10.1007/s00415-017-8666-x This systematic review confirmed that the risk of recurrent cerebral venous thrombosis and other venous thromboembolism is low during subsequent pregnancies.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José M. Ferro.

Ethics declarations

Conflict of Interest

José M. Ferro reports personal fees from Boehringer Ingelheim (principal investigator RE-SPECT CVT trial) during the conduct of the study. Dr. Ferro also reports grants from Boehringer Ingelheim, outside the submitted work, and grants and personal fees from Bayer, outside the submitted work. Diana Aguiar de Sousa declares no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Stroke

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferro, J.M., Aguiar de Sousa, D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep 19, 74 (2019). https://doi.org/10.1007/s11910-019-0988-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-019-0988-x

Keywords

Navigation